Department of Rheumatology, Infectious Diseases and Laboratory Medicine, University of Miyazaki, Japan.
Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, University of Miyazaki, Japan.
Intern Med. 2020 Aug 1;59(15):1891-1897. doi: 10.2169/internalmedicine.4455-20. Epub 2020 Apr 23.
A 61-year-old woman with human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) and interstitial pneumonia (IP) was admitted to our hospital. She complained of sicca symptoms, polyarthralgia, and swollen joints. She was diagnosed with rheumatoid arthritis (RA) and Sjögren's syndrome. Methotrexate and anti-tumor necrosis factor therapy were not utilized because of the inclusion of severe respiratory disorders among the complications and the neurological symptoms of HAM/TSP. Tocilizumab monotherapy improved the RA disease activity without exacerbating HAM/TSP. The present case suggests that tocilizumab might be a suitable treatment option in patients with RA and HAM/TSP.
一位 61 岁女性,患有人类 T 细胞白血病病毒 1 型(HTLV-1)相关脊髓病(HAM)/热带痉挛性截瘫(TSP)和间质性肺炎(IP),被收入我院。她主诉有干燥症状、多关节痛和关节肿胀。她被诊断为类风湿关节炎(RA)和干燥综合征。由于包括严重的呼吸障碍在内的并发症和 HAM/TSP 的神经症状,未采用甲氨蝶呤和抗肿瘤坏死因子治疗。托珠单抗单药治疗改善了 RA 疾病活动度,而没有加重 HAM/TSP。本病例提示,托珠单抗可能是 RA 合并 HAM/TSP 患者的一种合适治疗选择。